AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ERLOTINIB HYDROCHLORIDE

19 registrations across 5 African markets— 18 active

Markets with ERLOTINIB HYDROCHLORIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
ERLOCIP 150
TABLETS
🇷🇼RwandaCIPLA LTDactiveAug 2029
ERLOCIP 100
TABLETS
🇷🇼RwandaCIPLA LTDactiveAug 2029
ERLOCIP 150
TABLET, COATED; ORAL
🇿🇼ZimbabweCIPLA LTDactiveMay 2029
ERLOZ​ ​TABLETS🇬🇭GhanaactiveAug 2028
ERLOZ​ ​TABLETS🇬🇭GhanaactiveAug 2028
TYREC 150🇿🇦South AfricaKAHMA BIOTECH (Pty) LtdactiveJan 2028
TYREC 100🇿🇦South AfricaJuno Pharma SA (Pty) LtdactiveJan 2028
TYREC 25🇿🇦South AfricaJuno Pharma SA (Pty) LtdactiveJan 2028
ERLOTYK 150
TABLET, COATED; ORAL
🇿🇼ZimbabweMSN LABORATORIES LTDactiveDec 2027
ERLOTINIB CIPLA 25🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedMay 2025
ERLOTINIB CIPLA 100🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ERLOCIP 150🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ERLOCIP 100🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ERLOTINIB CIPLA 150🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ERLOCIP 25🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ERLOTINIB HYDROCHLORIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active
ERLOTINIB HYDROCHLORIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active
ERLOTINIB HYDROCHLORIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active
ERLOTINIB HYDROCHLORIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaCIPLA LTD.active

ERLOTINIB HYDROCHLORIDE in Africa — Regulatory Overview

ERLOTINIB HYDROCHLORIDE is registered across 5 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Ghana, Rwanda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 19 registrations, 18 (95%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.